Mouse Erythropoietin/EPO DuoSet ELISA, 15 Plate

• Reactivity: Mu
• Applications: ELISA
• Conjugate: Biotin

Mouse Erythropoietin/EPO DuoSet ELISA, 15 Plate Summary

• Source: N/A
• Assay Type: Solid Phase Sandwich ELISA
• Inter-Assay: See PDF Datasheet for details
• Intra-Assay: See PDF Datasheet for details
• Spike Recovery: See PDF Datasheet for details
• Sample Volume: See PDF Datasheet for details
• Gene: Epo

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: No significant interference observed with available related molecules.

Packaging, Storage & Formulations

• Storage: Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Mouse Erythropoietin/EPO DuoSet ELISA, 15 Plate

• ECYT5
• EP
• EPO
• epoetin
• Erythropoietin
• MGC138142
• MVCD2

Background

Erythropoietin (Epo) is a 34-39 kDa secreted glycoprotein that is a member of the type I cytokine superfamily. The mouse Epo gene encodes a 192 amino acid (aa) residue precursor that contains a 26 aa signal peptide and a 166 aa mature protein containing three potential N-linked glycosylation sites (1-4). Mouse Epo lacks the O-linked glycosylation site found in human Epo. Although carbohydrate chains are not required for in vitro receptor binding, they are required for in vivo Epo bioactivity. Depending on the cell source, different Epo isoforms are produced that differ in their glycan compositions and sialic acid contents (5-8). Mature mouse and rat Epo share 94% aa sequence identity. They also share from 80%-82% aa identity with mature human, porcine, rhesus monkey and feline Epo (2, 3). Epo is primarily produced by cells in the kidney (interstitial peritubular renal fibroblasts) and liver (hepatocytes and Ito cells), where its production is up-regulated by hypoxia. Other tissues and cells, including neural tissues (astrocytes and neurons), testis (Sertoli cells), uterus, placenta, and erythroid progenitors, have also been shown to produce Epo (9-14). 

Epo is best known for its role in red blood cell formation. While Epo is not a lineage commitment factor, it inhibits apoptosis and induces burst forming unit-erythroid (BFU-E) differentiation into colony forming unit-erythroid (CFU-E), and the subsequent proliferation and maturation of CFU-E into early normoblasts (10, 15, 16). Apart from its role in erythropoiesis, Epo also acts on various non-hematopoietic cells to function as a viability and proliferation factor. Epo can stimulate myoblast proliferation while suppressing its differentiation, resulting in the expansion of the progenitor cell population (17). Epo is a tissueprotective factor that protects against ischemic and toxic injuries to neuronal, cardiovascular and renal tissues (18, 19). Epo has also been shown to promote angiogenesis in various physiologic and pathologic conditions (20, 21). 

Epo binds and signals via the high-affinity preformed homodimeric Epo receptor (Epo R) that is composed of two Epo R subunits. Each Epo R subunit is a type I transmembrane glycoprotein that belongs to the type I cytokine receptor superfamily (18, 22-24). Its extracellular domain contains the characteristic two fibronectin type III domains and a WSxWS motif near the plasma membrane (24, 25). Binding of Epo to the Epo R homodimer results in conformational change and phosphorylation and activation of the non-receptor protein kinase JAK2, which activates the downstream signaling cascade (26). An alternative Epo heteromeric receptor complex that transduces cell-protective signals and containing the beta common receptor ( beta CR) subunit in addition to the Epo R subunit has been described. beta CR also belongs to the type I cytokine receptor superfamily and is a subunit that is shared by the heteromeric IL-3, IL-5 and GM-CSF receptor complexes. Epo binds with lower affinity to the heteromeric receptor consisting of a Epo R subunit and a beta CR homodimer (18).

Publications for Erythropoietin/EPO (DY959)(5)

Publications using DY959

• Zeydabadinejad, S;Theis, BF;Park, JS;Gohara, AF;Vijay-Kumar, M;Yeoh, BS;Saha, P; Pharmacologic Inhibition of Erythrocyte Ferroportin Expression Exacerbates Plasmodium Infection Microorganisms 2025-08-08 [PMID: 40871363] (Mouse)
• Zeydabadinejad, S;Kim, JSA;Zheng, A;Kandalgaonkar, MR;Ababio, PB;Vijay-Kumar, M;Yeoh, BS;Saha, P; Targeting anemia-induced CD71+ reticulocytes protects mice from Plasmodium infection Infection and Immunity 2025-07-01 [PMID: 40590713] (Mouse)
• Lang, A;Collins, JM;Nijsure, MP;Belali, S;Khan, MP;Moharrer, Y;Schipani, E;Yien, YY;Fan, Y;Gelinsky, M;Vinogradov, SA;Koch, C;Boerckel, JD; Local erythropoiesis directs oxygen availability in bone fracture repair bioRxiv : the preprint server for biology 2025-01-11 [PMID: 39829797] (Mouse)
• Park, MY;Agoro, R;Jankauskas, SS;Le Henaff, C;Sitara, D; Phosphorus-independent role of FGF23 in erythropoiesis and iron homeostasis PloS one 2024-12-12 [PMID: 39666728] (Mouse)
• N Nyffenegge, A Flace, C Doucerain, F Dürrenberg, V Manolova The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of &beta-Thalassemia International Journal of Molecular Sciences, 2021-01-16;22(2):. 2021-01-16 [PMID: 33467196] (Mouse)

FAQs for Erythropoietin/EPO (DY959). (Showing 1 - 1 of 1 FAQs).

1. wondering what the difference is between your quantikine and duo set elisas?
   • Usually the duosets do not have the entire kit such as plates and buffers, whereas the other kits are complete.

Bioinformatics

• Gene Symbol: Epo